Literature DB >> 21160817

Hypocaloric peripheral parenteral nutrition with lipid emulsion in postoperative gastrointestinal cancer patients.

Chien-Yu Lu1, Hung-Yi Chuang, Fang-Jung Yu, Li-Chu Sun, Ying-Ling Shih, Fang-Ming Chen, Jan-Sing Hsieh, Jaw-Yuan Wang.   

Abstract

AIM: To investigate the use of lipid emulsion substituting for glucose in postoperative hypocaloric peripheral parenteral nutrition (HPPN).
METHODS: This prospective, randomized study was conducted on 20 postoperative gastrointestinal cancer patients. They were randomized and equally divided into interventional group and control group, and both were administered isocaloric and isonitrogenous diets with for lipid emulsion substituting for partial glucose loads in the interventional group.
RESULTS: Nutritional parameters and biochemical data were compared between the two groups before and after 6-d of HPPN. Most investigated variables showed no significant changes after administration of HPPN with lipid emulsion. However, the postoperative triglyceride level was significantly lower in the interventional group than in the control group (P < 0.05). In comparison with lipid emulsion, glucose administration resulted in less decrease in postoperative prealbumin level (P < 0.05).
CONCLUSION: In addition to supplementing with essential fatty acid, it seems that HPPN with lipid emulsion is well-tolerated and beneficial to postoperative gastrointestinal cancer patients.

Entities:  

Keywords:  Dextrose; Hypocaloric peripheral parenteral nutrition; Lipid emulsion

Year:  2010        PMID: 21160817      PMCID: PMC2999150          DOI: 10.4251/wjgo.v2.i1.51

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  23 in total

1.  Perioperative total parenteral nutrition in surgical patients.

Authors: 
Journal:  N Engl J Med       Date:  1991-08-22       Impact factor: 91.245

2.  Effects of intravenously administered fructose and glucose on splanchnic secretion of plasma triglycerides in hypertriglyceridemic men.

Authors:  B M Wolfe; S P Ahuja
Journal:  Metabolism       Date:  1977-09       Impact factor: 8.694

3.  Effects of isoenergetic glucose-based or lipid-based parenteral nutrition on glucose metabolism, de novo lipogenesis, and respiratory gas exchanges in critically ill patients.

Authors:  L Tappy; J M Schwarz; P Schneiter; C Cayeux; J P Revelly; C K Fagerquist; E Jéquier; R Chioléro
Journal:  Crit Care Med       Date:  1998-05       Impact factor: 7.598

Review 4.  Hyperinsulinemia and triglyceride-rich lipoproteins.

Authors:  G Steiner; G F Lewis
Journal:  Diabetes       Date:  1996-07       Impact factor: 9.461

5.  Human plasma lipoproteins and total parenteral nutrition with intravenous fat emulsion.

Authors:  R H Judd; H Freund; R J Deckelbaum
Journal:  JPEN J Parenter Enteral Nutr       Date:  1984 Sep-Oct       Impact factor: 4.016

6.  Ventilatory response to high caloric loads in critically ill patients.

Authors:  J M Liposky; L D Nelson
Journal:  Crit Care Med       Date:  1994-05       Impact factor: 7.598

7.  Efficacy of a high-carbohydrate diet in catabolic illness.

Authors:  D W Hart; S E Wolf; X J Zhang; D L Chinkes; M C Buffalo; S I Matin; M A DebRoy; R R Wolfe; D N Herndon
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

8.  Effect of parenteral hyperalimentation on serum lipoproteins and on lipoprotein lipase activity of adipose tissue and skeletal muscle.

Authors:  M R Taskinen; I Tulikoura; E A Nikkilä; C Ehnholm
Journal:  Eur J Clin Invest       Date:  1981-08       Impact factor: 4.686

9.  Protein-sparing effect of substrate infusion in surgical patients is governed by the clinical state, and not by the individual substrate infused.

Authors:  J H Shaw; C M Holdaway
Journal:  JPEN J Parenter Enteral Nutr       Date:  1988 Sep-Oct       Impact factor: 4.016

10.  Postoperative parenteral nutrition while proactively minimizing insulin resistance.

Authors:  Monika Svanfeldt; Anders Thorell; Jonas Nygren; Olle Ljungqvist
Journal:  Nutrition       Date:  2006-02-13       Impact factor: 4.008

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.